written on 30.04.2014

Rise in patient reporting boosts EU drug safety signals


The introduction of direct reporting of adverse drug reactions by patients in Europe appears to have had the desired effect: in 2013, the number of ADRs reported by patients within the European Economic Area (EEA) rose by more than 50% as a result of…